SAT-452 Results from the Phase 3 Multicenter SONICS Study of Levoketoconazole: Subgroup Analysis of Cushing's Syndrome (CS) Patients with Diabetes Mellitus (DM)

Background: Cushing’s syndrome (CS) has numerous comorbidities, including diabetes mellitus (DM).(1) Levoketoconazole is a ketoconazole stereoisomer in clinical trials for the treatment of CS. Methods: SONICS is a prospective, open-label, phase 3 maintenance-of-benefit study in adults with confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleseriu, Maria, Pivonello, Rosario, Elenkova, Atanaska, Salvatori, Roberto, Auchus, Richard, Feelders, Richard, Geer, Eliza, Greenman, Yona, Witek, Przemyslaw, Cohen, Fredric, Biller, Beverly MK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551748/
http://dx.doi.org/10.1210/js.2019-SAT-452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551748/
http://dx.doi.org/10.1210/js.2019-SAT-452

Ejemplares similares